SULFATIERTE C19-STEROID-HORMONE ZUR BEHANDLUNG UND/ODER VORBEUGUNG VON PROTEOTOXIZITÄT IN PROTEINAGGREGATIONSERKRANKUNGEN
Patent europeic · EP4232021 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP4232021
- Numer da la dumonda
- EP21798711
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 26-10-2021
- Publitgà
- 30-08-2023
- Concedì
- 27-05-2026
- La protecziun finescha il pli tard
- 25-10-2041
- Proxima taxa annuala scadenta
- 31-10-2027
- Classas IPC
- A61K 31/37 (2006.01)A61K 31/568 (2006.01)A61K 31/5685 (2006.01)A61P 25/16 (2006.01)A61P 25/28 (2006.01)
- Prioritad
- EP 20382931 26.10.2020
- Dumonda PCT
- PCT/EP2021/079710 26.10.2021
- Publicaziun PCT
- WO2022/090247 05.05.2022
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-11-2026
Next annual fee due on
- Next annual fee due on
- 31.10.2026 → 31.10.2027
Published in Swissreg on 01.11.2026
- 17-07-2026
Represchentant inscrit
- Representative
- BOVARD AG, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 17.07.2026
- 27-05-2026
Concedì
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 27.05.2026
Partidas
Represchentant
Inventur
MUÑOZ, Manuel J.
41013 Sevilla, ES
PÉREZ-JIMÉNEZ, Mercedes M.
41013 Sevilla, ES
CARRIÓN, Ángel M.
41013 Sevilla, ES
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.